SHUR IQ // Issue No. 14 | AXIV · U.S. OTC Cold, Flu, Immune Support 2026-05-18
← Visualization Hub View Editorial Brief →

Command Center

One frame, six panels. The SBPI score and pentagon, the four whitespace positions, the conversation map, the bridging words, the headline opportunity, and the numbers that anchor the brief.

Issue No. 14 · 2026-05-18
SBPI
33
out of 100
Vulnerable
Composite of five dimensions. Mission at 42 is the closest to crossing into a stronger band.
Five-Dimension Shape
Where the brand is strong and thin
Top Opportunity
The one move the brief is built around
Critical · Gap 4
Latin American clean medicine for the U.S. Hispanic and bilingual household

None of the major U.S. brands carry a bilingual front-of-pack panel, a Spanish-language education program, or a Latin American pharmaceutical heritage. AXIV's Argentine parent has thirty years of manufacturing under Savant Pharm. The most defensible position the brand can take, and the strategic frame from which the other three gaps follow.

Category Map
Nine conversations, simplified
Each color is a conversation. Bigger circles are the words that connect across conversations.
Whitespace Inventory
Four open positions
Hispanic & bilingual natural-immune
Critical
Daytime relief without heavy ingredients
High
Stay-well to get-better handoff
High
Clean & natural mucus management
Medium
Conversation Share
Which talk carries the category
Words That Bridge
Most-connected terms
zinc
01
flu
02
cold
03
elderberry
04
Numbers That Anchor
The headline scorecard
14
Brands compared
9
Conversations
4
Whitespace gaps
30m
AXIV onset claim
19%
U.S. Hispanic share
0
Bilingual U.S. peers